Related Experiment Video
Updated: Sep 18, 2025

Isolation and Genome Analysis of Single Virions using 'Single Virus Genomics'
Published on: May 26, 2013
Isolation and complete genome sequence of a novel Mycobacterium phage MS619
Qiqi Zhao1, Xinpu Shi1, Mingshuai Liu1
1School of Basic Medical Sciences and Forensic Medicine, Hangzhou Medical College, Hangzhou, 310000, Zhejiang, People's Republic of China.
Abstract:
Mycobacterium, an opportunistic pathogen, is highly prone to causing infections in humans, and its resistance to antibiotics poses a significant challenge. Phage therapy has emerged as a highly promising alternative treatment. In this study, a bacteriophage infecting Mycobacterium smegmatis was isolated from soil, named MS619, and classified within the class Caudoviricetes. Phages have an icosahedral head (60 ± 2 nm in diameter) and a long, non-contractile tail with a size of 125 ± 2 nm. The genome of MS619 was found to be a double-stranded DNA composed of 48,955 bp, containing 76 open reading frames (ORFs), related to phage packaging, structure, lysin, regulation, and replication. The BLASTN results indicated that MS619 exhibits a high-sequence identity (93%) with Mycobacterium phage Georgie2, a known bacteriophage recorded in the NCBI GenBank database. A typical holin-lysin system was identified in the MS619 genome. The topology of holin was predicted to contain two transmembrane domains, which significantly contribute to antimicrobial activity. No antibiotic resistance- or virulence factor-related genes were detected in the phage. Moreover, the bacteriophage demonstrates biofilm growth inhibition capability. This study led to the isolation of MS619, a bacteriophage exhibiting potential antibacterial efficacy against Mycobacterium infections.
Insights
A novel bacteriophage, MS619, was isolated to combat Mycobacterium infections. This phage shows potential antibacterial activity and biofilm inhibition, offering a promising alternative to antibiotics.
Area of Science:
- Microbiology
- Virology
- Genomics
Background:
- Mycobacterium species are opportunistic pathogens causing human infections.
- Antibiotic resistance in Mycobacterium presents a significant clinical challenge.
- Bacteriophage therapy is a promising alternative treatment strategy.
Purpose of the Study:
- To isolate and characterize a novel bacteriophage effective against Mycobacterium.
- To evaluate the potential of the isolated bacteriophage as an antibacterial agent.
Main Methods:
- Isolation of bacteriophage MS619 from soil.
- Morphological characterization (icosahedral head, non-contractile tail).
- Genomic analysis (48,955 bp dsDNA, 76 ORFs) and BLASTN comparison.
- Identification of holin-lysin system and absence of resistance/virulence genes.
Main Results:
- MS619, a Caudoviricetes phage, was isolated and characterized.
- Its genome contains 76 ORFs related to phage functions.
- MS619 shares 93% sequence identity with Mycobacterium phage Georgie2.
- The phage possesses a holin-lysin system and inhibits biofilm growth.
- No antibiotic resistance or virulence genes were detected in MS619.
Conclusions:
- MS619 is a novel bacteriophage with potential therapeutic applications against Mycobacterium infections.
- The phage's mechanism involves a holin-lysin system and biofilm inhibition.
- MS619 represents a promising candidate for phage therapy due to its safety profile and efficacy.
Related Concept Videos
DNA Bacteriophages
Lysogenic Cycle of Bacteriophages
Lytic Cycle of Bacteriophages

